BeStock  
Stocks › PHAR

Pharming Group PHAR

US equityMarket cap rank #3529
$9.65 −$0.03 (-0.31%)
Pre-market · Oct 8, 9:00 am ET · After hours $9.65 0.00%
Open$9.65
Prev close$9.68
Day range$9.59 – $9.75
Volume3,833
Market cap$683.01M
P/E (TTM)68.9
Dividend yield–

PHAR Stock News

Headlines matching Pharming Group or the PHAR ticker, most recent first.

  • CCORF Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $38Market news · 30 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $37Market news · 30 Sep 2026 · Direct mention
  • CCORF Maintains Pharming Group(PHAR.US) With Buy Rating, Raises Target Price to $38 PositiveMarket news · 3 Aug 2026 · Direct mention
  • EXTRAWELL PHAR: FORM OF PROXY FOR USE BY SHAREHOLDERS AT THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, 28 AUGUST 2026 AT 11:00 A.M.HKEX · 30 Jul 2026 · Direct mention
  • CCORF Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $37Market news · 23 Jun 2026 · Direct mention
  • Oppenheimer Maintains Pharming Group(PHAR.US) With Buy Rating, Cuts Target Price to $40 NegativeMarket news · 8 May 2026 · Direct mention
  • CCORF Initiates Pharming Group(PHAR.US) With Buy Rating, Announces Target Price $37Market news · 10 Apr 2026 · Direct mention
  • Oppenheimer Maintains Pharming Group(PHAR.US) With Buy Rating, Cuts Target Price to $41 NegativeMarket news · 13 Mar 2026 · Direct mention
  • Oppenheimer Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $42Market news · 4 Feb 2026 · Direct mention
  • Pharming Group (PHAR) Receives a Buy From H.C. WainwrightTipRanks · 28 Jan 2026 · Direct mention
  • TR | OpenAI - 4o Upgrades Pharming Group(PHAR.US) to Buy Rating, Raises Target Price to $13.5 PositiveMarket news · 6 Aug 2025 · Direct mention
  • TR | OpenAI - 4o Maintains Pharming Group(PHAR.US) With Hold Rating, Cuts Target Price to $13 NegativeMarket news · 12 Aug 2025 · Direct mention
  • TR | OpenAI - 4o Downgrades Pharming Group(PHAR.US) to Hold Rating, Raises Target Price to $14.5 MixedMarket news · 11 Aug 2025 · Direct mention
  • Oppenheimer Maintains Pharming Group(PHAR.US) With Buy Rating, Raises Target Price to $41 PositiveMarket news · 1 Aug 2025 · Direct mention
  • EXTRAWELL PHAR: FORM OF PROXY FOR USE BY SHAREHOLDERS AT THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, 22 AUGUST 2025 AT 11:00 A.M.HKEX · 28 Jul 2025 · Direct mention

Discussion

No comments yet — be the first to weigh in on PHAR.

Leave a comment

Scroll to Top